|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research |
H Nyblom, Medical Cell Biology, Uppsala University, Uppsala, 75123, Sweden
E Sargsyan, Medical Cell Biology, Uppsala University, Uppsala, Sweden
P Bergsten, Medical Cell Biology, Uppsala University, Uppsala, Sweden
Correspondence: Hanna Nyblom, Email: Hanna.Nyblom{at}mcb.uu.se
Abstract
Prolonged hyperglycaemia leads to impaired glucose-stimulated insulin secretion (GSIS) and apoptosis in insulin-producing β-cells. The detrimental effects have been connected with glucose-induced lipid accumulation in the β-cell. AMP-activated protein kinase (AMPK) agonist 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) promotes utilization of nutrient stores for energy production. It was tested how impaired GSIS and elevated apoptosis observed in INS-1E cells after prolonged culture at 27 mM glucose was affected by inclusion of 0.3 or 1 mM AICAR during culture. Glucose-induced impairment of insulin release was reverted by inclusion of 0.3 but not 1 mM AICAR, which did not affect insulin content. The glucose-induced rise in triglyceride content observed in cells cultured at 27 mM glucose was not altered by inclusion of either 0.3 or 1 mM AICAR. Inclusion of 1 but not 0.3 mM AICAR during culture induced phosphorylation of AMPK and its down-stream target acyl-CoA carboxylase. Phosphorylation was paralleled by reduced number of apoptotic cells and lowered expression of pro-apoptotic protein CHOP. In conclusion, AICAR dose-dependently improves β-cell function and reduces apoptosis in β-cells exposed to prolonged hyperglycaemia without changing triglyceride levels.
This article has been cited by other articles:
![]() |
A. Zulli, E. Lau, B. P.P. Wijaya, X. Jin, K. Sutarga, G. D. Schwartz, J. Learmont, P. J. Wookey, A. Zinellu, C. Carru, et al. High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia Hypertension, June 1, 2009; 53(6): 1017 - 1022. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |